<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1405-0099</journal-id>
<journal-title><![CDATA[Cirujano general]]></journal-title>
<abbrev-journal-title><![CDATA[Cir. gen]]></abbrev-journal-title>
<issn>1405-0099</issn>
<publisher>
<publisher-name><![CDATA[Asociación Mexicana de Cirugía General A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1405-00992018000400230</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Plasma rico en plaquetas alogénico activado sobre injertos de piel en pacientes con quemaduras grado III]]></article-title>
<article-title xml:lang="en"><![CDATA[Allogeneic activated platelet-rich plasma in skin grafts of patients with grade III burns]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[García-Salas]]></surname>
<given-names><![CDATA[José Daniel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Carrillo-Gorena]]></surname>
<given-names><![CDATA[Javier]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cisneros-Castolo]]></surname>
<given-names><![CDATA[Martín]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sierra-Santiesteban]]></surname>
<given-names><![CDATA[Francisca]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Enríquez-Sánchez]]></surname>
<given-names><![CDATA[Luis]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,UACH  ]]></institution>
<addr-line><![CDATA[Chihuahua ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Central del Estado de Chihuahua División Quirúrgica ]]></institution>
<addr-line><![CDATA[Chihuahua ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Hospital Infantil de Especialidades de Chihuahua Servicio de la Unidad de Vigilancia Epidemiológica ]]></institution>
<addr-line><![CDATA[Chihuahua ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Hospital General de Chihuahua Departamento de Patología ]]></institution>
<addr-line><![CDATA[Chihuahua ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af5">
<institution><![CDATA[,Hospital Central del Estado de Chihuahua Departamento de Cirugía General ]]></institution>
<addr-line><![CDATA[Chihuahua ]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2018</year>
</pub-date>
<volume>40</volume>
<numero>4</numero>
<fpage>230</fpage>
<lpage>237</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S1405-00992018000400230&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S1405-00992018000400230&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S1405-00992018000400230&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Objetivo:  Comparar el porcentaje de adhesión y curso clínico en pacientes con quemaduras de tercer grado tratados con injerto cutáneo delgado mallado libre autólogo (más el uso de plasma rico en plaquetas alogénico activado) contra el placebo con solución fisiológica al 0.9%.  Material y métodos:  De febrero a mayo de 2016 se estudiaron 10 pacientes atendidos en la Unidad de Quemados del Hospital General del Estado de Chihuahua con quemaduras de tercer grado menores de 35% de superficie corporal total, candidatos a tratamiento con injerto cutáneo delgado mallado libre (ICDML) autólogo. Se determinaron aleatoriamente por medio de sorteo cinco pacientes para tratamiento con plasma rico en plaquetas activado y cinco para placebo con solución fisiológica al 0.9% como tratamiento agregado. Se tomó muestra de injerto con dermatomo eléctrico Padgett y se utilizó mallador de injerto cutáneo Brennen proporción 3:1. Se tomó el concentrado plaquetario a razón de 1 cc por 4 cm2 de superficie de injerto, se mezcló con trombina bovina 28 U/ml y gluconato de calcio 2.8 mg/ml. Hay que esperar cinco minutos a que las plaquetas se degranulen y con un instrumento romo se deshace el coágulo formado. Se tomó la mezcla resultante con una jeringa de 10 cc y aguja No. 23 y se infiltró en el tejido celular subcutáneo 0.5 cc con una separación de 2 cm en sentido longitudinal y lateral.  Resultados:  El grupo de pacientes sometidos a tratamiento con plasma rico en plaquetas alogénico activado (PRPAA) presentó una adhesión clínica del injerto de 100% en comparación con la media de 92% del grupo placebo. Se observó 20% de cultivos positivos para infección en el grupo caso vs. 80% con cultivos positivos del grupo control. Histopatológicamente se detectó en el grupo placebo menor epitelización al quinto día de la colocación del injerto vs. el grupo del PRPAA en el que se observó aumento del grosor en el estrato córneo, incremento de vasos de neovascularización por campo y reacción granulomatosa.  Conclusiones:  El uso de PRPAA en pacientes con quemaduras de tercer grado que son sometidos a injerto cutáneo delgado mallado libre muestra ventajas en el curso clínico, porcentaje de adhesión y disminución de infecciones vs. pacientes tratados con placebo.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Objective:  To compare the percentage of adhesion and clinical course in patients with third degree burns treated with autologous free meshed thin skin graft plus the use of activated allogeneic platelet rich plasma in relation to whom activated platelet rich plasma was not applied and then were given 0.9% physiological solution as a placebo.  Material and methods:  From February to May 2016, 10 patients who were treated at the Hospital General del Estado de Chihuahua Burn Unit. They were studied with third degree burns below 35% of total body surface area. All were candidates for treatment with a free mesh skin graft. Five patients were randomly assigned to treatment with activated platelet rich plasma and the other five patients were assigned to a placebo with 0.9% saline solution as an aggregate treatment. An injector sample is taken with Padgett electric dermatome, and a 3: 1 Brennen skin graft mesh was used. the platelet concentrate at a rate of 1 cc per 4 cm2 of graft surface, mix with bovine thrombin 28 U/ml and calcium gluconate 2.8 mg/ml, wait 5 minutes for the platelets to evacuate, dissolve the coagulum formed with a blunt instrument, the resulting mixture is taken with a 10 cc syringe and No. 23 needle and it is infiltrated in a surgical bed in 0.5 cc subcutaneous tissue with a separation of 2 cm in the longitudinal and lateral direction.  Results:  In the group of patients treated with allogeneic activated platelet-rich plasma (PRPAA), the clinical adhesion of the graft was 100% compared to the 92% average of the placebo group. 20% of positive cultures for infection in the case group vs 80% with positive cultures of the control group. Histopathologically, a lower epithelialization was found in the placebo group on the fifth day of graft placement vs the PRPAA group, where increased thickness in the corneal layer was observed, neovascularization vessels increased per field and the granulomatous reaction.  Conclusions:  The use of PRPAA in patients with third-degree burns who undergo a free-cut, thin-skinned graft shows advantages in the clinical course, via the percentage of adhesion and decrease in infection vs patients treated with a placebo.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[adhesión]]></kwd>
<kwd lng="es"><![CDATA[área cruenta]]></kwd>
<kwd lng="es"><![CDATA[injerto mallado]]></kwd>
<kwd lng="es"><![CDATA[angiogénesis]]></kwd>
<kwd lng="es"><![CDATA[epitelización]]></kwd>
<kwd lng="es"><![CDATA[plasma rico en plaquetas]]></kwd>
<kwd lng="es"><![CDATA[quemaduras de III grado]]></kwd>
<kwd lng="en"><![CDATA[Adhesion]]></kwd>
<kwd lng="en"><![CDATA[bloody area]]></kwd>
<kwd lng="en"><![CDATA[mesh graft]]></kwd>
<kwd lng="en"><![CDATA[angiogenesis]]></kwd>
<kwd lng="en"><![CDATA[epithelization]]></kwd>
<kwd lng="en"><![CDATA[platelet-rich plasma]]></kwd>
<kwd lng="en"><![CDATA[III degree burns]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Venter]]></surname>
<given-names><![CDATA[NG]]></given-names>
</name>
<name>
<surname><![CDATA[Marques]]></surname>
<given-names><![CDATA[RG]]></given-names>
</name>
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Monte-Alto-Costa]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Use of platelet-rich plasma in deep second- and third-degree burns]]></article-title>
<source><![CDATA[Burns]]></source>
<year>2016</year>
<volume>42</volume>
<page-range>807-14</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kadam]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Novel expansion techniques for skin grafts]]></article-title>
<source><![CDATA[Indian J Plast Surg]]></source>
<year>2016</year>
<volume>49</volume>
<page-range>5-15</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Beldon]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[What you need to know about skin grafts and donor site wounds]]></article-title>
<source><![CDATA[Wound Essentials]]></source>
<year>2007</year>
<volume>2</volume>
<page-range>149-55</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Herndon]]></surname>
<given-names><![CDATA[DN]]></given-names>
</name>
</person-group>
<source><![CDATA[Total burn care]]></source>
<year>2012</year>
<edition>4</edition>
<page-range>80-92</page-range><publisher-name><![CDATA[Elsevier]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thourani]]></surname>
<given-names><![CDATA[VH]]></given-names>
</name>
<name>
<surname><![CDATA[Ingram]]></surname>
<given-names><![CDATA[WL]]></given-names>
</name>
<name>
<surname><![CDATA[Feliciano]]></surname>
<given-names><![CDATA[DV]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factors affecting success of split-thickness skin grafts in the modern burn unit]]></article-title>
<source><![CDATA[J Trauma]]></source>
<year>2003</year>
<volume>54</volume>
<page-range>562-8</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ki-Chan]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Jang-Seok]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Jung-Han]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Dong-Min]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Analysis of factors that affect the outcome of skin grafts]]></article-title>
<source><![CDATA[J Korean Orthop Assoc]]></source>
<year>2012</year>
<volume>47</volume>
<page-range>119-24</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Smrke]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Gubina]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Domanoviç]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Rozman]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Allogeneic platelet gel with autologous cancellous bone graft for the treatment of a large bone defect]]></article-title>
<source><![CDATA[Eur Surg Res]]></source>
<year>2007</year>
<volume>39</volume>
<page-range>170-4</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carrillo-Mora]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[González-Villalva]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Macías-Hernández]]></surname>
<given-names><![CDATA[SI]]></given-names>
</name>
<name>
<surname><![CDATA[Pineda-Villaseñor]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Plasma rico en plaquetas. Herramienta versátil de la medicina regenerativa]]></article-title>
<source><![CDATA[Cir Cir]]></source>
<year>2013</year>
<volume>81</volume>
<page-range>74-82</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marck]]></surname>
<given-names><![CDATA[RE]]></given-names>
</name>
<name>
<surname><![CDATA[Gardien]]></surname>
<given-names><![CDATA[KL]]></given-names>
</name>
<name>
<surname><![CDATA[Stekelenburg]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Vehmeijer]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Baas]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Tuinebreijer]]></surname>
<given-names><![CDATA[WE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The application of platelet-rich plasma in the treatment of deep dermal burns: A randomized, double-blind, intra-patient controlled study]]></article-title>
<source><![CDATA[Wound Repair Regen]]></source>
<year>2016</year>
<volume>24</volume>
<page-range>712-20</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Amable]]></surname>
<given-names><![CDATA[PR]]></given-names>
</name>
<name>
<surname><![CDATA[Carias]]></surname>
<given-names><![CDATA[RB]]></given-names>
</name>
<name>
<surname><![CDATA[Teixeira]]></surname>
<given-names><![CDATA[MV]]></given-names>
</name>
<name>
<surname><![CDATA[da Cruz Pacheco]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Corrêa do Amaral]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[Granjeiro]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors]]></article-title>
<source><![CDATA[Stem Cell Res Ther]]></source>
<year>2013</year>
<volume>4</volume>
<page-range>67</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arora]]></surname>
<given-names><![CDATA[NS]]></given-names>
</name>
<name>
<surname><![CDATA[Ramanayake]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Ren]]></surname>
<given-names><![CDATA[YF]]></given-names>
</name>
<name>
<surname><![CDATA[Romanos]]></surname>
<given-names><![CDATA[GE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Platelet-rich plasma: a literature review]]></article-title>
<source><![CDATA[Implant Dent]]></source>
<year>2009</year>
<volume>18</volume>
<page-range>303-10</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[HM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Curative effect of autologous platelet-rich plasma on a large cutaneous lesion in a dog]]></article-title>
<source><![CDATA[Vet Dermatol]]></source>
<year>2009</year>
<volume>20</volume>
<page-range>123-6</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marck]]></surname>
<given-names><![CDATA[RE]]></given-names>
</name>
<name>
<surname><![CDATA[Middelkoop]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Breederveld]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Considerations on the use of platelet-rich plasma, specifically for burn treatment]]></article-title>
<source><![CDATA[J Burn Care Res]]></source>
<year>2014</year>
<volume>35</volume>
<page-range>219-27</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Picard]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Hersant]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Bosc]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Meningaud]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The growing evidence for the use of platelet-rich plasma on diabetic chronic wounds: A review and a proposal for a new standard care]]></article-title>
<source><![CDATA[Wound Repair Regen]]></source>
<year>2015</year>
<volume>23</volume>
<page-range>638-43</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kakudo]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Kushida]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Minakata]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Suzuki]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Kusumoto]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Platelet-rich plasma promotes epithelialization and angiogenesis in a splitthickness skin graft donor site]]></article-title>
<source><![CDATA[Med Mol Morphol]]></source>
<year>2011</year>
<volume>44</volume>
<page-range>233-6</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schade]]></surname>
<given-names><![CDATA[VL]]></given-names>
</name>
<name>
<surname><![CDATA[Roukis]]></surname>
<given-names><![CDATA[TS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Use of platelet-rich plasma with split-thickness skin grafts in the high-risk patient]]></article-title>
<source><![CDATA[Foot Ankle Spec]]></source>
<year>2008</year>
<volume>1</volume>
<page-range>155-9</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kaffashi Elahi]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Mousavi]]></surname>
<given-names><![CDATA[GH]]></given-names>
</name>
<name>
<surname><![CDATA[Mohajeri]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effects of topical heterologous blood serum and bovine thrombin activated platelet rich plasma on experimental corneal stromal ulcers in rabbit]]></article-title>
<source><![CDATA[Adv Environ Biol]]></source>
<year>2012</year>
<volume>6</volume>
<page-range>95-9</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moctezuma]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Páez]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Miguel]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Foncerrada]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiología de las quemaduras en México]]></article-title>
<source><![CDATA[Rev Esp Méd Quir]]></source>
<year>2015</year>
<volume>20</volume>
<page-range>78-82</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Clark]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Imran]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Madni]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Wolf]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nutrition and metabolism in burn patients]]></article-title>
<source><![CDATA[Burns Trauma]]></source>
<year>2017</year>
<volume>5</volume>
<page-range>11</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kagan]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[Peck]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
<name>
<surname><![CDATA[Ahrenholz]]></surname>
<given-names><![CDATA[DH]]></given-names>
</name>
<name>
<surname><![CDATA[Hickerson]]></surname>
<given-names><![CDATA[WL]]></given-names>
</name>
<name>
<surname><![CDATA[Holmes]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Korentager]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Surgical management of the burn wound and use of skin substitutes: an expert panel white paper]]></article-title>
<source><![CDATA[J Burn Care Res]]></source>
<year>2013</year>
<volume>34</volume>
<page-range>e60-79</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Baxter]]></surname>
<given-names><![CDATA[CR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Management of burn wounds]]></article-title>
<source><![CDATA[Dermatol Clin]]></source>
<year>1993</year>
<volume>11</volume>
<page-range>709-14</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
